|
⚲
|
| Keyboard |
| Pontes Josias
✚
|
|
|---|---|
| CIK # | 0001868415 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001868415] | |
| 4 | [0001868415] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sigilon Therapeutics Inc | |
| Pontes Josias |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sigilon Therapeutics Inc SGTX
Common Stock
|
2023-08-11 | Disposed to issuer | 3,504 | ||
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-08-11 | Disposed to issuer | 10,767 | $0.75 | 8,075 |
|
Sigilon Therapeutics Inc SGTX
Common Stock
|
2023-07-21 | Option exercise | 1,444 | $19.24 | 27,783 |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-07-21 | Option exercise | 1,444 | $0.00 | |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-02-28 | Grant | 140,000 | $0.00 | |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2022-02-18 | Grant | 60,000 | $1.48 | 88,800 |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2022-01-03 | Grant | 65,000 | $3.03 | 196,950 |
|
Sigilon Therapeutics Inc SGTX
Common Stock
|
2021-09-30 | Grant | 11,500 | $0.00 |